Motion Sickness Relief Tablet
Product Images NDC 21130-778

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Motion Sickness Relief (NDC 21130-778). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Better Living Brands, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Signature Care 44-403 (Signature Care 44 403 1)

This is a drug package for medications that help prevent motion sickness. The package contains twelve tablets. The active ingredient in each tablet is Meclizine HCI 25 mg. It is suggested to take one to two tablets one hour before starting an activity that may induce motion sickness. It also includes warnings and instructions for use. The product comes with a money-back satisfaction guarantee. The package recommends retaining the vial card for complete product information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.